Stock Scorecard



Stock Summary for Lilly(Eli) & Company (LLY) - $753.41 as of 11/20/2024 8:23:27 PM EST

Total Score

7 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for LLY

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for LLY

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for LLY

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for LLY

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for LLY (65 out of 90)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 6
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 6
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 2

Latest News for for LLY

J&J Loses Around $24B in a Month: How to Play the Stock? 11/20/2024 8:00:00 PM
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate - Eli Lilly ( NYSE:LLY ) 11/20/2024 7:56:00 PM
BioRestorative Ends Q3 In 'Strong' Financial Position, Reports Positive Data For Its Phase 2 BRTX-100 Chronic Back Pain Trial - Eli Lilly ( NYSE:LLY ) , BioRestorative Therapies ( NASDAQ:BRTX ) 11/20/2024 1:03:00 PM
Is It Time to Sell Eli Lilly and Pfizer Stocks? 11/20/2024 10:48:00 AM
The Zacks Analyst Blog Highlights Eli Lilly, PepsiCo and Morgan Stanley 11/20/2024 10:00:00 AM
Top Research Reports for Eli Lilly, PepsiCo & Morgan Stanley 11/19/2024 9:18:00 PM
LLY Oral Cholesterol Drug Lowers Lipoprotein Levels in Phase II Study 11/19/2024 8:00:00 PM
Eli Lilly's Investigational Drug Cuts Sticky Cholesterol Levels By Almost 86% - Eli Lilly ( NYSE:LLY ) 11/19/2024 6:08:00 PM
Jim Cramer: Coinbase Is A 'Winner,' Suggests Buying This 'Hated' Big Pharma Stock - Eli Lilly ( NYSE:LLY ) 11/19/2024 5:01:00 PM
Eli Lilly Unusual Options Activity - Eli Lilly ( NYSE:LLY ) 11/19/2024 3:46:00 PM

Financial Details for LLY

Company Overview

Ticker LLY
Company Name Lilly(Eli) & Company
Country USA
Description Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2024
Next Earnings Date 2/4/2025

Stock Price History

Last Day Price 753.41
Price 4 Years Ago 161.45
Last Day Price Updated 11/20/2024 8:23:27 PM EST
Last Day Volume 5,116,185
Average Daily Volume 4,029,972
52-Week High 970.92
52-Week Low 558.01
Last Price to 52 Week Low 35.02%

Valuation Measures

Trailing PE 80.67
Industry PE 22.60
Sector PE 40.32
5-Year Average PE 60.89
Free Cash Flow Ratio 203.08
Industry Free Cash Flow Ratio 12.03
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 1.27
Total Cash Per Share 3.71
Book Value Per Share Most Recent Quarter 15.82
Price to Book Ratio 49.75
Industry Price to Book Ratio 5.31
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 17.34
Industry Price to Sales Ratio Twelve Trailing Months 11.82
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 15
Analyst Strong Buy Ratings 7

Share Statistics

Total Shares Outstanding 949,316,000
Market Capitalization 715,224,167,560
Institutional Ownership N/A

Dividends

Ex-Dividend Date 11/15/2024
Last Dividend Amount 1.30
Current Dividend Amount 1.30
Total Years Dividend Increasing 9
Trailing Annual Dividend Rate 5.20
Trailing Annual Dividend Yield 0.69%
Forward Annual Dividend Rate 5.98
Forward Annual Dividend Yield 0.79%
5-Year Dividend Payments Count 20
3-Year Average Dividend Yield 1.03%
5-Year Average Dividend Yield 1.36%
1-Year Dividend Growth Rate Percentage 15.31%
3-Year Dividend Growth Rate Percentage 15.30%
5-Year Dividend Growth Rate Percentage 15.05%
All-Time Dividend Growth Rate Percentage 8.44%
Dividend Payout Ratio 56.22%

Income Statement

Quarterly Earnings Growth YOY 68.20%
Annual Earnings Growth -16.08%
Reported EPS 12 Trailing Months 9.25
Reported EPS Past Year 7.68
Reported EPS Prior Year 6.32
Net Income Twelve Trailing Months 8,369,900,000
Net Income Past Year 5,240,400,000
Net Income Prior Year 6,244,800,000
Quarterly Revenue Growth YOY 20.40%
5-Year Revenue Growth 9.69%
Operating Margin Twelve Trailing Months 0.40

Balance Sheet

Total Cash Most Recent Quarter 3,518,400,000
Total Cash Past Year 2,927,700,000
Total Cash Prior Year 2,211,800,000
Net Cash Position Most Recent Quarter -26,306,000,000
Net Cash Position Past Year -16,108,200,000
Long Term Debt Past Year 19,035,900,000
Long Term Debt Prior Year 14,815,300,000
Total Debt Most Recent Quarter 29,824,400,000
Equity to Debt Ratio Past Year 0.36
Equity to Debt Ratio Most Recent Quarter 0.32
Total Stockholder Equity Past Year 10,771,900,000
Total Stockholder Equity Prior Year 10,649,800,000
Total Stockholder Equity Most Recent Quarter 14,240,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 1,399,800,000
Free Cash Flow Per Share Twelve Trailing Months 1.47
Free Cash Flow Past Year 792,500,000
Free Cash Flow Prior Year 5,731,400,000

Options

Put/Call Ratio 1.05
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -24.41
MACD Signal -23.34
20-Day Bollinger Lower Band 783.26
20-Day Bollinger Middle Band 887.06
20-Day Bollinger Upper Band 990.85
Beta 0.43
RSI 39.29
50-Day SMA 792.25
150-Day SMA 511.56
200-Day SMA 438.21

System

Modified 11/19/2024 5:34:27 AM EST